重组人脂联素对SD大鼠胫骨骨折愈合过程的影响

Effect of recombinant adiponectin on fracture healing in SD rats

  • 摘要:
      背景  脂联素是血清中最普遍的脂肪因子,可以影响骨形成和骨吸收。而脂联素能否促进骨折愈合仍未确定。
      目的  研究重组人脂联素对SD大鼠胫骨闭合性骨折愈合的影响。
      方法  使用2月龄SD雄性大鼠24只,体质量约200 g,采用骨折造模器制作SD大鼠胫骨骨折模型。造模成功后,将大鼠随机分为3组(每组n=8),并即刻局部注射0.5 mL药物1次,治疗1组注射脂联素剂量为1 mg/kg、治疗2组注射脂联素剂量为2 mg/kg,对照组注射等量0.9%氯化钠注射液。在造模成功后第6周时处死大鼠并取出双侧胫骨,通过HE染色观察骨痂结构,Masson染色评价骨痂成熟度,免疫荧光染色观察成骨相关因子表达,micro-CT检测骨痂微结构评价脂联素对SD大鼠胫骨骨折愈合的影响。
      结果  骨折后6周时HE染色显示:治疗组骨痂明显增厚,板层骨形成均优于对照组。Masson染色显示:治疗组大鼠胫骨骨痂处胶原蛋白更多,骨痂成熟度优于对照组。免疫荧光染色显示:脂联素1 mg/kg组和2 mg/kg组在骨膜处、骨陷窝和生发层处的促成骨因子骨钙素(osteocalcin,OCN)表达量(0.61%±0.21%和0.44%±0.17% vs 0.27%±0.17%)、碱性磷酸酶(alkaline phosphatase,ALP)表达量(0.85%±0.62%和0.70%±0.34% vs 0.35%±0.15%)均高于对照组(P<0.05)。micro-CT分析显示:脂联素1 mg/kg治疗组骨痂处骨体积分数(BV/TV)(53.76±7.89 vs 26.37±4.32)%、骨小梁厚度(Tb.Th) (363.9±51.45) μm vs (269.6±36.80) μm、骨小梁数量(Tb.N) (15.68±2.11)/cm vs (10.51±1.49)/cm和骨小梁分离度(Tb.Sp)(344.6±98.79) μm vs (604.3±78.27) μm均优于对照组(P<0.05)。脂联素 2 mg/kg治疗组骨痂处BV/TV 45.10%±5.45%、Tb.N(14.4±1.83)/cm和Tb.Sp(436.1±63.75) μm也优于对照组(P<0.05),骨小梁厚度与对照组比较,差异无统计学意义。脂联素1 mg/kg组与2 mg/kg组各指标差异无统计学意义。
      结论  脂联素可以促进SD大鼠的骨痂生长,骨微结构重建,促进成骨因子表达,缩短骨折愈合时间。

     

    Abstract:
      Background  Adiponectin, a common adipocytokine in serum, can affect bone formation and bone resorption. However, whether it can promote fracture healing still remains uncertain.
      Objective  To study the effect of recombinant adiponectin on the tibial fractures in SD rats.
      Methods  Twenty four 2-month-old SD male rats with a body weight of 200g were collected. After the fracture model was established, the rats were randomly divided into three groups and immediately injected 0.5 mL adiponectin or 0.9% NaCl once locally. Adiponectin (1 mg/kg) was given to rats in the treatment group 1 (n=8), 2 mg/kg for treatment group 2 (n=8), and control group (n=8) was given 0.9% NaCl. At 6 weeks after modeling, the rats were sacrificed and bilateral tibias were collected. Callus structure was observed by HE and Masson staining. Osteogenic related factors were observed by immunofluorescence staining. Callus microstructure was detected by Micro-CT to evaluate the effect of adiponectin on tibial fracture.
      Results  HE staining results showed that the callus of the treatment group was significantly thickened and lamellar bone formation was better than the control group. Masson staining results showed that the treatment group had more collagen in the tibial callus, and the callus maturity was better than the control group. Immunofluorescence staining results showed that in periosteum, bone lacunae and hair layer, the adiponectin 1 mg/kg group and the adiponectin 2 mg/kg group had significantly higher OCN and ALP expressions than those of the control group (OCN: 0.61% ± 0.21% and 0.44% ± 0.17% vs 0.27% ± 0.17%; ALP: 0.85% ± 0.62% and 0.70% ± 0.34% vs 0.35% ± 0.15%; P<0.05, respectively). Results of Micro-CT showed that the bone callus volume fraction (BV/TV: 53.76% ± 7.89% vs 26.37% ± 4.32%), trabecular thickness (Tb.Th: 363.9 ± 51.45 μm vs 269.6 ± 36.80 μm), trabecular number (Tb.N: 15.68 ± 2.11/cm vs 10.51 ± 1.49/cm) and degree of separation (Tb.Sp: 344.6 ± 98.79 μm vs 604.3 ± 78.27 μm) in adiponectin 1 mg/kg group were better than those of the control group (all P<0.05). The same trends were observed in adiponectin 2 mg/kg group (BV/TV: 45.10%±5.45%, Tb.N: 14.4±1.83/cm and Tb.Sp: 436.1±63.75µm) and the control group (all P<0.05), but there was no significant difference in the thickness of bone trabecular. Adiponectin 1 mg/kg group and 2 mg/kg group had no significant difference in these parameters.
      Conclusion  Adiponectin can promote callus growth, bone microstructural reconstruction and the expression of osteogenic factors, so as to shorten the time of fracture healing in SD rats.

     

/

返回文章
返回